SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies’ Q3 net profit jumps by 55%

08 Feb 2013 Evaluate

Pharmaceutical manufacturing company, Venus Remedies, has reported result for third quarter ended December 31, 2012.

The company’s net profit for the quarter jumped by 55.37% at Rs 16.05 crore as compared to Rs 10.33 crore for the same quarter in the previous financial year. Total income from operation of the company rose by 17.54% at Rs 112.63 crore for quarter under review as compared to Rs 95.82 crore for the quarter ended December 31, 2011.

Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.

Venus Remedies Share Price

968.50 35.75 (3.83%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×